Quetiapine Fumarate

富马酸喹硫平

Report date: 2026/01/14 09:47:39
NME

Base Information

Drug NameQuetiapine Fumarate
Drug Alias Namequetiapinum喹硫平quetiapina富马酸奎硫平Quetiapine extended release +[20] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsBipolar II DisorderBipolar I DisorderStress Disorders, Post-Traumatic +[30] 
Global Approved IndicationsSchizophreniaBipolar DisorderDepression
Approved Indications in ChinaSchizophreniaBipolar Disorder
Original Approved Country/TerritoryUnited States
Original Approved Date1997/09/26
Country/TerritoryBelgiumBulgariaCanada +[47] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesZuellig Pharma IncUT Health San AntonioMoksha8 Pharmaceuticals Inc +[11] 
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseyWeill Medical College of Cornell UniversityHannover Medical School +[27] 
Active IndicationsStress Disorders, Post-TraumaticSchizophreniaDepressive Disorder +[6] 
Inactive IndicationsBipolar II DisorderBipolar I DisorderPsychotic Disorders +[24] 

Other Information

ATC CodeN05AH04
Related LinksWikipediaDrugBankKEGG